Neuramin (Thiamine)

Thiamine, the active ingredient in Neuramin, is a vitamin (B1) presented as an injectable solution for intramuscular and intravenous use. It addresses thiamine deficiency conditions such as beriberi and Wernicke’s encephalopathy in patients at risk of inadequate vitamin B1 levels.

GNH USA supplies Neuramin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neuramin is used to treat disorders related to thiamine deficiency and its metabolic consequences. - Thiamine deficiency (beriberi): restores normal carbohydrate metabolism and alleviates cardiovascular and neurological symptoms. - Wernicke's encephalopathy: prevents progression of acute neurological damage in at‑risk individuals. - At‑risk populations (e.g., chronic alcoholism, malnutrition): maintains adequate thiamine levels to support energy production and nerve function.

Thiamine administered intravenously or intramuscularly may be associated with a range of adverse reactions.

Common Side Effects: - Injection site pain or erythema - Nausea or vomiting - Headache - Dizziness or light‑headedness - Transient flushing - Mild fever

Serious or Rare Side Effects: - Anaphylactic reaction - Severe hypersensitivity (rash, angioedema) - Hypotension or cardiovascular collapse - Cardiac arrhythmias - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Seizures

Thiamine should be used with consideration of patient‑specific factors and proper handling. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: assess risk‑benefit ratio with a clinician. - Renal impairment: monitor for accumulation and adjust therapy if needed. - Hepatic impairment: use with caution and observe liver function. - Concomitant medications: review potential interactions before initiating therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Thiamine may interact with certain drugs, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - High‑dose phenobarbital or other enzyme‑inducing anti‑epileptics: may increase thiamine metabolism and reduce effectiveness. - Known hypersensitivity to thiamine or formulation excipients: avoid administration.

Moderate Interactions (Monitor Closely): - Chronic alcohol consumption: can increase thiamine requirement and diminish response. - Loop diuretics (e.g., furosemide): may enhance urinary thiamine loss. - Metformin: potential alteration of thiamine absorption. - Warfarin: monitor INR as vitamin B1 may affect coagulation parameters. - Other B‑vitamin supplements: assess for synergistic effects and adjust dosing if necessary.